Total Payments
$48,241
2024 Payments
$8,784
Companies
64
Transactions
1,110
Medicare Patients
4,371
Medicare Billing
$1.2M
Payment Breakdown by Category
Other$27,858 (57.7%)
Food & Beverage$19,956 (41.4%)
Education$257.81 (0.5%)
Travel$168.92 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $26,858 | 33 | 55.7% |
| Food and Beverage | $19,956 | 1,069 | 41.4% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $1,000 | 1 | 2.1% |
| Education | $257.81 | 6 | 0.5% |
| Travel and Lodging | $168.92 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $15,014 | 102 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $10,950 | 17 | $0 (2021) |
| Allergan, Inc. | $3,620 | 77 | $0 (2022) |
| LivaNova USA, Inc. | $1,562 | 14 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,430 | 96 | $0 (2024) |
| GENZYME CORPORATION | $1,268 | 60 | $0 (2023) |
| Biogen, Inc. | $1,222 | 69 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $866.01 | 43 | $0 (2024) |
| EMD Serono, Inc. | $756.29 | 48 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $743.91 | 38 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $8,784 | 142 | ABBVIE INC. ($5,682) |
| 2023 | $9,955 | 131 | ABBVIE INC. ($7,902) |
| 2022 | $2,589 | 133 | ABBVIE INC. ($463.69) |
| 2021 | $14,771 | 140 | Biohaven Pharmaceuticals, Inc. ($10,950) |
| 2020 | $3,528 | 101 | Allergan, Inc. ($1,963) |
| 2019 | $2,952 | 164 | Novartis Pharmaceuticals Corporation ($380.94) |
| 2018 | $3,440 | 149 | LivaNova USA, Inc. ($1,000) |
| 2017 | $2,222 | 150 | Sunovion Pharmaceuticals Inc. ($289.21) |
All Payment Transactions
1,110 individual payment records from CMS Open Payments — Page 1 of 45
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $28.51 | General |
| Category: NEUROSCIENCE | ||||||
| 12/18/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $23.10 | General |
| Category: Neuropsychiatry | ||||||
| 12/13/2024 | Amneal Pharmaceuticals LLC | ONGENTYS (Drug) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: NEUROLOGY | ||||||
| 12/11/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $9.57 | General |
| Category: NEUROSCIENCE | ||||||
| 12/06/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $14.41 | General |
| Category: Neuroscience | ||||||
| 12/06/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $3.93 | General |
| Category: Neurology | ||||||
| 12/05/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $34.37 | General |
| Category: Neurology | ||||||
| 12/04/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $24.46 | General |
| 12/04/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $5.63 | General |
| Category: Neurology | ||||||
| 12/03/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $28.72 | General |
| Category: Neurology | ||||||
| 11/27/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $25.54 | General |
| Category: Neurology | ||||||
| 11/25/2024 | ABBVIE INC. | QULIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,625.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $25.76 | General |
| Category: Neurology | ||||||
| 11/20/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $2.96 | General |
| 11/15/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: Neuropsychiatry | ||||||
| 11/14/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $6.86 | General |
| Category: NEUROLOGY | ||||||
| 11/14/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $3.20 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $42.02 | General |
| 11/09/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $22.54 | General |
| Category: Neurology | ||||||
| 11/07/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: PAIN | ||||||
| 11/06/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $24.31 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $8.28 | General |
| Category: NEUROSCIENCE | ||||||
| 11/01/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $20.86 | General |
| Category: NEUROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,072 | 28,648 | $1.1M | $276,876 |
| 2022 | 18 | 1,040 | 31,838 | $1.1M | $283,056 |
| 2021 | 19 | 1,104 | 33,862 | $1.1M | $309,777 |
| 2020 | 19 | 1,155 | 31,418 | $1.1M | $292,314 |
Total Patients
4,371
Total Services
125,766
Medicare Billing
$1.2M
Procedure Codes
71
All Medicare Procedures & Services
71 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 43 | 27,155 | $488,790 | $132,704 | 27.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 204 | 388 | $81,480 | $33,321 | 40.9% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 160 | 179 | $147,172 | $28,174 | 19.1% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 168 | 356 | $97,375 | $26,303 | 27.0% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 38 | 100 | $46,400 | $11,149 | 24.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 83 | 83 | $34,943 | $9,905 | 28.3% |
| 93886 | Complete ultrasound of within the brain blood flow | Office | 2023 | 51 | 52 | $37,128 | $8,472 | 22.8% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 56 | 57 | $39,102 | $6,771 | 17.3% |
| 93893 | Ultrasound of within the brain blood flow for blood clots with microbubble injection | Office | 2023 | 52 | 53 | $35,192 | $6,666 | 18.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 49 | 49 | $30,282 | $3,585 | 11.8% |
| 95924 | Testing of autonomic (sympathetic and parasympathetic) nervous system function, at least 5 minutes of tilt | Office | 2023 | 23 | 24 | $7,416 | $2,816 | 38.0% |
| 96116 | Exam of neurobehavioral status, first hour | Office | 2023 | 41 | 43 | $12,900 | $2,734 | 21.2% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2023 | 22 | 23 | $10,718 | $2,171 | 20.3% |
| 96139 | Administration of psychological or neuropsychological test by technician, each additional 30 minutes | Office | 2023 | 41 | 43 | $5,535 | $1,073 | 19.4% |
| 96138 | Administration of psychological or neuropsychological test by technician, first 30 minutes | Office | 2023 | 41 | 43 | $6,235 | $1,032 | 16.6% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 47 | 30,400 | $530,400 | $143,522 | 27.1% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 163 | 177 | $144,255 | $27,755 | 19.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 170 | 318 | $66,780 | $27,464 | 41.1% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 172 | 354 | $88,700 | $27,154 | 30.6% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2022 | 48 | 134 | $62,176 | $13,703 | 22.0% |
| 93886 | Complete ultrasound of within the brain blood flow | Office | 2022 | 49 | 49 | $34,986 | $8,011 | 22.9% |
| 93893 | Ultrasound of within the brain blood flow for blood clots with microbubble injection | Office | 2022 | 49 | 49 | $32,536 | $6,320 | 19.4% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2022 | 51 | 52 | $35,672 | $6,271 | 17.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 49 | 49 | $20,629 | $5,908 | 28.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 40 | 48 | $12,672 | $4,362 | 34.4% |
About Dr. Mohammad Taher, MD
Dr. Mohammad Taher, MD is a Neurology healthcare provider based in American Fork, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1992762918.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mohammad Taher, MD has received a total of $48,241 in payments from pharmaceutical and medical device companies, with $8,784 received in 2024. These payments were reported across 1,110 transactions from 64 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($26,858).
As a Medicare-enrolled provider, Taher has provided services to 4,371 Medicare beneficiaries, totaling 125,766 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 71 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Neurology
- Location American Fork, UT
- Active Since 04/26/2006
- Last Updated 10/27/2022
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1992762918
Products in Payments
- NURTEC ODT (Drug) $11,180
- UBRELVY (Drug) $8,632
- QULIPTA (Drug) $8,364
- VNS Therapy (Device) $1,545
- BOTOX (Biological) $1,348
- AUBAGIO (Drug) $1,003
- TYSABRI (Biological) $934.48
- INGREZZA (Drug) $746.53
- APTIOM (Drug) $729.32
- OCREVUS (Biological) $681.49
- RYTARY (Drug) $596.40
- KESIMPTA (Drug) $549.53
- Briviact (Drug) $541.21
- ZEPOSIA (Drug) $523.39
- NUPLAZID (Drug) $470.56
- EMGALITY (Drug) $426.37
- Gocovri (Drug) $362.49
- GILENYA (Drug) $304.40
- Aimovig (Biological) $302.26
- GOCOVRI (Drug) $261.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.